Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Enhanced glacial discharge from the eastern Antarctic Peninsula since the 1700s associated with a positive Southern Annular Mode.

Dickens WA, Kuhn G, Leng MJ, Graham AGC, Dowdeswell JA, Meredith MP, Hillenbrand CD, Hodgson DA, Roberts SJ, Sloane H, Smith JA.

Sci Rep. 2019 Oct 24;9(1):14606. doi: 10.1038/s41598-019-50897-4.

2.

Anomalous Stoichiometry, 3-D Bridged Triangular/Pentagonal Layered Structured Artificial Antiferromagnet for the Prussian Blue Analogue A3MnII5(CN)13 (A = NMe4, NEtMe3). A Cation Adaptive Structure.

Lapidus SH, Graham AG, Kareis CM, Hawkins CG, Stephens PW, Miller JS.

J Am Chem Soc. 2019 Jan 16;141(2):911-921. doi: 10.1021/jacs.8b10638. Epub 2019 Jan 4.

PMID:
30557002
3.

Hard rock landforms generate 130 km ice shelf channels through water focusing in basal corrugations.

Jeofry H, Ross N, Le Brocq A, Graham AGC, Li J, Gogineni P, Morlighem M, Jordan T, Siegert MJ.

Nat Commun. 2018 Nov 1;9(1):4576. doi: 10.1038/s41467-018-06679-z.

4.

Diverse landscapes beneath Pine Island Glacier influence ice flow.

Bingham RG, Vaughan DG, King EC, Davies D, Cornford SL, Smith AM, Arthern RJ, Brisbourne AM, De Rydt J, Graham AGC, Spagnolo M, Marsh OJ, Shean DE.

Nat Commun. 2017 Nov 20;8(1):1618. doi: 10.1038/s41467-017-01597-y.

5.

Limited grounding-line advance onto the West Antarctic continental shelf in the easternmost Amundsen Sea Embayment during the last glacial period.

Klages JP, Kuhn G, Hillenbrand CD, Smith JA, Graham AGC, Nitsche FO, Frederichs T, Jernas PE, Gohl K, Wacker L.

PLoS One. 2017 Jul 25;12(7):e0181593. doi: 10.1371/journal.pone.0181593. eCollection 2017.

6.

Cation Dependence of the Dimerization Enthalpy for A2 [tetracyanoethylene]2 (A=NMe4 , Mepy, NEt4 ) Possessing a Long, Multicenter Bond.

Graham AG, Fedin MV, Miller JS.

Chemistry. 2017 Sep 12;23(51):12620-12629. doi: 10.1002/chem.201702492. Epub 2017 Aug 15.

PMID:
28654716
7.

Major advance of South Georgia glaciers during the Antarctic Cold Reversal following extensive sub-Antarctic glaciation.

Graham AG, Kuhn G, Meisel O, Hillenbrand CD, Hodgson DA, Ehrmann W, Wacker L, Wintersteller P, Dos Santos Ferreira C, Römer M, White D, Bohrmann G.

Nat Commun. 2017 Mar 17;8:14798. doi: 10.1038/ncomms14798.

8.

A New Conformation With an Extraordinarily Long, 3.04 Å Two-Electron, Six-Center Bond Observed for the π-[TCNE]2 (2-) Dimer in [NMe4 ]2 [TCNE]2 (TCNE=Tetracyanoethylene).

Graham AG, Mota F, Shurdha E, Rheingold AL, Novoa JJ, Miller JS.

Chemistry. 2015 Sep 14;21(38):13145. doi: 10.1002/chem.201502903.

PMID:
26332225
9.

A New Conformation With an Extraordinarily Long, 3.04 Å Two-Electron, Six-Center Bond Observed for the π-[TCNE]2 (2-) Dimer in [NMe4 ]2 [TCNE]2 (TCNE=Tetracyanoethylene).

Graham AG, Mota F, Shurdha E, Rheingold AL, Novoa JJ, Miller JS.

Chemistry. 2015 Sep 14;21(38):13240-5. doi: 10.1002/chem.201501963. Epub 2015 Jul 29.

PMID:
26223479
10.

The discovery of new deep-sea hydrothermal vent communities in the southern ocean and implications for biogeography.

Rogers AD, Tyler PA, Connelly DP, Copley JT, James R, Larter RD, Linse K, Mills RA, Garabato AN, Pancost RD, Pearce DA, Polunin NV, German CR, Shank T, Boersch-Supan PH, Alker BJ, Aquilina A, Bennett SA, Clarke A, Dinley RJ, Graham AG, Green DR, Hawkes JA, Hepburn L, Hilario A, Huvenne VA, Marsh L, Ramirez-Llodra E, Reid WD, Roterman CN, Sweeting CJ, Thatje S, Zwirglmaier K.

PLoS Biol. 2012 Jan;10(1):e1001234. doi: 10.1371/journal.pbio.1001234. Epub 2012 Jan 3.

11.

Structure-activity relationships of the p38alpha MAP kinase inhibitor 1-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)naph- thalen-1-yl]urea (BIRB 796).

Regan J, Capolino A, Cirillo PF, Gilmore T, Graham AG, Hickey E, Kroe RR, Madwed J, Moriak M, Nelson R, Pargellis CA, Swinamer A, Torcellini C, Tsang M, Moss N.

J Med Chem. 2003 Oct 23;46(22):4676-86.

PMID:
14561087
12.

Pyrazole urea-based inhibitors of p38 MAP kinase: from lead compound to clinical candidate.

Regan J, Breitfelder S, Cirillo P, Gilmore T, Graham AG, Hickey E, Klaus B, Madwed J, Moriak M, Moss N, Pargellis C, Pav S, Proto A, Swinamer A, Tong L, Torcellini C.

J Med Chem. 2002 Jul 4;45(14):2994-3008.

PMID:
12086485
13.

Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site.

Pargellis C, Tong L, Churchill L, Cirillo PF, Gilmore T, Graham AG, Grob PM, Hickey ER, Moss N, Pav S, Regan J.

Nat Struct Biol. 2002 Apr;9(4):268-72.

PMID:
11896401
14.

Antiinflammatory 2-benzyl-4-sulfonyl-4H-isoquinoline-1,3-diones: novel inhibitors of COX-2.

Lazer ES, Sorcek R, Cywin CL, Thome D, Possanza GJ, Graham AG, Churchill L.

Bioorg Med Chem Lett. 1998 May 19;8(10):1181-6.

PMID:
9871731
15.

Effect of structural modification of enol-carboxamide-type nonsteroidal antiinflammatory drugs on COX-2/COX-1 selectivity.

Lazer ES, Miao CK, Cywin CL, Sorcek R, Wong HC, Meng Z, Potocki I, Hoermann M, Snow RJ, Tschantz MA, Kelly TA, McNeil DW, Coutts SJ, Churchill L, Graham AG, David E, Grob PM, Engel W, Meier H, Trummlitz G.

J Med Chem. 1997 Mar 14;40(6):980-9.

PMID:
9083488
16.

Inhibition of lipid mediator biosynthesis in human inflammatory cells by BIRM 270.

Parks TP, Hoffman AF, Homon CA, Graham AG, Lazer ES, Chilton FH, Borgeat P, Raible D, Schulman E, Bass DA, et al.

Agents Actions Suppl. 1995;46:139-46. Review.

PMID:
7610984
17.

BIRM 270: a novel inhibitor of arachidonate release that blocks leukotriene B4 and platelet-activating factor biosynthesis in human neutrophils.

Farina PR, Graham AG, Hoffman AF, Watrous JM, Borgeat P, Nadeau M, Hansen G, Dinallo RM, Adams J, Miao CK, et al.

J Pharmacol Exp Ther. 1994 Dec;271(3):1418-26.

PMID:
7996454
18.

Benzoxazolamines and benzothiazolamines: potent, enantioselective inhibitors of leukotriene biosynthesis with a novel mechanism of action.

Lazer ES, Miao CK, Wong HC, Sorcek R, Spero DM, Gilman A, Pal K, Behnke M, Graham AG, Watrous JM, et al.

J Med Chem. 1994 Apr 1;37(7):913-23.

PMID:
8151618
19.

A prodrug of a 2,6-disubstituted 4-(2-arylethenyl)phenol is a selective and orally active 5-lipoxygenase inhibitor.

Farina PR, Graham AG, Homon CA, Lazer ES, Hattox SE, Riska PS, Gundel RH, Wegner CD.

J Pharmacol Exp Ther. 1993 May;265(2):483-9.

PMID:
8388452
20.

The role of 5-lipoxygenase products in preclinical models of asthma.

Wegner CD, Gundel RH, Abraham WM, Schulman ES, Kontny MJ, Lazer ES, Homon CA, Graham AG, Torcellini CA, Clarke CC, et al.

J Allergy Clin Immunol. 1993 Apr;91(4):917-29.

PMID:
8473681
21.

Effect of structure on potency and selectivity in 2,6-disubstituted 4-(2-arylethenyl)phenol lipoxygenase inhibitors.

Lazer ES, Wong HC, Wegner CD, Graham AG, Farina PR.

J Med Chem. 1990 Jul;33(7):1892-8.

PMID:
2113949
22.

Urothelial tumours of the upper urinary tract.

Kirkali Z, Moffat LE, Deane RF, Kyle KF, Graham AG.

Br J Urol. 1989 Jul;64(1):18-24.

PMID:
2765765
23.

Antiinflammatory 2,6-di-tert-butyl-4-(2-arylethenyl)phenols.

Lazer ES, Wong HC, Possanza GJ, Graham AG, Farina PR.

J Med Chem. 1989 Jan;32(1):100-4.

PMID:
2491889
24.

Blood groups and transitional cell carcinoma of the upper urinary tract.

Kirkali Z, Deane RF, Kyle KF, Graham AG.

Eur Urol. 1988;14(1):22-3.

PMID:
3342801
25.

The changing trend in prostatectomy in a district general hospital.

Conn IG, Moffat LE, Graham AG.

Ann R Coll Surg Engl. 1986 May;68(3):174. No abstract available.

26.

The decision on surgery in renal artery stenosis.

Mackay A, Boyle P, Brown JJ, Cumming AM, Forrest H, Graham AG, Lever AF, Robertson JI, Semple PF.

Q J Med. 1983 Summer;52(207):363-81.

PMID:
6359228
27.
28.

Assessment of total and divided renal plasma flow by 123I-hippuran renography.

Mackay A, Eadie AS, Cumming AM, Graham AG, Adams FG, Horton PW.

Kidney Int. 1981 Jan;19(1):49-57.

29.

Changing the FRCS exam.

Graham AG.

Br Med J. 1977 Dec 3;2(6100):1482. No abstract available.

30.

Scottish prostates: a 6-year review.

Graham AG.

Br J Urol. 1977;49(7):679-82.

PMID:
597708
31.

Tobramycin in urinary tract infection.

Graham AG.

Scott Med J. 1976 Apr;21(2):75-6. No abstract available.

PMID:
941000
32.

Ultrasound in the staging of bladder tumours.

Mclaughlin IS, Morley P, Deane RF, Barnett E, Graham AG, Kyle KF.

Br J Urol. 1975 Feb;47(1):51-6.

PMID:
1131496
33.

Proceedings: A case of carcinosarcoma of ureter.

McDade HB, Armstrong EM, Graham AG.

J Clin Pathol. 1974 Jun;27(6):514. No abstract available.

34.

Clinical experience with renal scanning using Hg197 chlormerodrin.

Graham AG, Scott JS, Kennedy I, Mack WS.

Br J Urol. 1967 Dec;39(6):718-26. No abstract available.

PMID:
6074269
35.

Heller-valve method of intravenous fluid administration in neonatal surgery.

Graham AG.

Br Med J. 1965 Nov 6;2(5470):1086-9. No abstract available.

36.

BLOOD LOSS IN PAEDIATRIC SURGERY.

GRAHAM AG.

Br Med J. 1964 Jul 25;2(5403):246. No abstract available.

37.

The Pierre Robin syndrome.

FORREST H, GRAHAM AG.

Scott Med J. 1963 Jan;8:16-24. No abstract available.

PMID:
13958778
38.

Renal sarcoidosis and nephrolithiasis.

ANDERSON GS, GRAHAM AG.

Scott Med J. 1960 Sep;5:392-6. No abstract available.

PMID:
13683202
39.

Recurrence of varicosity following 'high ligation'.

BROWN DB, GRAHAM AG, TOOMEY WF.

Scott Med J. 1960 Feb;5:88-91. No abstract available.

PMID:
13804902
40.

Hibernoma or brown-fat lipoma.

SANDISON AT, GRAHAM AG.

Scott Med J. 1959 Mar;4(3):120-2. No abstract available.

PMID:
13646653

Supplemental Content

Loading ...
Support Center